Krka d. d
Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. The company's prescription pharmaceuticals include medicines for the treatment of cardiovascular, gastrointestinal tract and metabolis… Read more
Krka d. d (KRK) - Total Assets
Latest total assets as of September 2025: zł2.97 Billion PLN
Based on the latest financial reports, Krka d. d (KRK) holds total assets worth zł2.97 Billion PLN as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Krka d. d - Total Assets Trend (2010–2024)
This chart illustrates how Krka d. d’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Krka d. d - Asset Composition Analysis
Current Asset Composition (December 2024)
Krka d. d's total assets of zł2.97 Billion consist of 64.1% current assets and 35.9% non-current assets.
| Asset Category | Amount (PLN) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | zł0.00 | 12.1% |
| Accounts Receivable | zł591.76 Million | 20.8% |
| Inventory | zł601.69 Million | 21.1% |
| Property, Plant & Equipment | zł0.00 | 0.0% |
| Intangible Assets | zł58.10 Million | 2.0% |
| Goodwill | zł42.64 Million | 1.5% |
Asset Composition Trend (2010–2024)
This chart illustrates how Krka d. d's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Krka d. d's current assets represent 64.1% of total assets in 2024, an increase from 43.1% in 2010.
- Cash Position: Cash and equivalents constituted 12.1% of total assets in 2024, up from 0.5% in 2010.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, a decrease from 27.0% in 2010.
- Asset Diversification: The largest asset category is inventory at 21.1% of total assets.
Krka d. d Competitors by Total Assets
Key competitors of Krka d. d based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
Krka d. d - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Krka d. d generates 0.67x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Excellent ROA - For every $100 in assets, Krka d. d generates $ 12.53 in net profit.
Krka d. d - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.91 | 3.82 | 4.00 |
| Quick Ratio | 2.67 | 2.55 | 2.55 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | zł1.43 Billion | zł 1.33 Billion | zł 933.61 Million |
Krka d. d - Advanced Valuation Insights
This section examines the relationship between Krka d. d's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.02 |
| Latest Market Cap to Assets Ratio | 1.51 |
| Asset Growth Rate (YoY) | 3.1% |
| Total Assets | zł2.85 Billion |
| Market Capitalization | $4.31 Billion USD |
Valuation Analysis
Above Book Valuation: The market values Krka d. d's assets above their book value (1.51 x), reflecting positive investor sentiment about the company's future prospects.
Positive Asset Growth: Krka d. d's assets grew by 3.1% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Krka d. d (2010–2024)
The table below shows the annual total assets of Krka d. d from 2010 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | zł2.85 Billion | +3.07% |
| 2023-12-31 | zł2.76 Billion | +2.86% |
| 2022-12-31 | zł2.69 Billion | +5.90% |
| 2021-12-31 | zł2.54 Billion | +13.52% |
| 2020-12-31 | zł2.24 Billion | +2.33% |
| 2019-12-31 | zł2.18 Billion | +10.05% |
| 2018-12-31 | zł1.99 Billion | +3.44% |
| 2017-12-31 | zł1.92 Billion | +0.40% |
| 2016-12-31 | zł1.91 Billion | +5.66% |
| 2015-12-31 | zł1.81 Billion | +0.75% |
| 2014-12-31 | zł1.80 Billion | +2.04% |
| 2013-12-31 | zł1.76 Billion | +8.18% |
| 2012-12-31 | zł1.63 Billion | +6.04% |
| 2011-12-31 | zł1.53 Billion | +3.08% |
| 2010-12-31 | zł1.49 Billion | -- |